COVID-19 vaccinations : summary guidance for cancer patients in 28 languages : breaking barriers to cancer patient information
Mauri, Davide and Lampriani, Tsali and Mario, Dambrosio and Berardino, De and Nadia, Hindi and Carl, Salembier and Nixon, Ioanna and Dimitrios, Tzachanis and Flippo, Alongi and Hassan, Hameed and Antonios, Valachis and Konstantinos, Papadimitriou and Stefanie, Corradini and Popovic, Lazar and Jindrich, Kopecky and Andres, Rodriguez and Katarina, Antunac and Junlin, Yi and Spahiu, Orges (2022) COVID-19 vaccinations : summary guidance for cancer patients in 28 languages : breaking barriers to cancer patient information. Reviews on Recent Clinical Trials, 17 (1). pp. 11-14. (https://doi.org/10.2174/1574887116666211028145848)
Preview |
Text.
Filename: Mauri_etal_RRCT_2021_Covid_19_vaccinations_summary_guidance_for_cancer_patients_in_28_languages.pdf
Final Published Version License: Download (2MB)| Preview |
Abstract
Background Covid-19 vaccination has started in the majority of the countries at the global level. Cancer patients are at high risk for infection, serious illness, and death from COVID-19 and need vaccination guidance and support. Guidance availability in the English language only is a major limit for recommendations' delivery and their application in the world’s population and generates information inequalities across the different populations. Methods Most of the available COVID-19 vaccination guidance for cancer patients was screened and scrutinized by the European Cancer Patients Coalition (ECPC) and an international oncology panel of 52 physicians from 33 countries.Results: A summary guidance was developed and provided in 28 languages in order to reach more than 70 percent of the global population. Conclusion Language barrier and e-guidance availability in the native language are the most important barriers when communicating with patients. E-guidance availability in various native languages should be considered a major priority by international medical and health organizations that are communicating with patients at the global level.
-
-
Item type: Article ID code: 80865 Dates: DateEvent3 January 2022Published28 October 2021Published Online26 August 2021AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Strathclyde Business School > Management Science Depositing user: Pure Administrator Date deposited: 25 May 2022 08:38 Last modified: 29 Jun 2024 02:28 URI: https://strathprints.strath.ac.uk/id/eprint/80865